To include your compound in the COVID-19 Resource Center, submit it here.
Immuno-oncology company Unum Therapeutics Inc. (Cambridge, Mass.) filed on March 2 to raise up to $86.3 million in an IPO on NASDAQ underwritten
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury